Because of its role in signalling by both TNF and ligands of the EGF receptor, it has been the focus of major pharmaceutical efforts, with a view to treating inflammatory diseases and cancer (Arribas & Esselens, 2009; Mustafi et al, 2017). The gene discussed is TNF; the disease is cancer.